X Mas Buffalo farm xmas orders Keytruda approved for prostate cancer clinical trial in China BeiGene invests $135 million to introduce DKK1 antibody to explore PD-1 combination therapy The first ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...